These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 1972995)
1. Comparison of the effects of three indirect dopamine agonists, GK 13, GBR 12783 and dexamphetamine on behavioural tests involving central catecholaminergic transmissions. Duterte-Boucher D; Kamenka JM; Costentin J Psychopharmacology (Berl); 1990; 101(3):344-53. PubMed ID: 1972995 [TBL] [Abstract][Full Text] [Related]
2. Anxiogenic-like effects induced by stimulation of dopamine receptors. Simon P; Panissaud C; Costentin J Pharmacol Biochem Behav; 1993 Jul; 45(3):685-90. PubMed ID: 8101381 [TBL] [Abstract][Full Text] [Related]
3. Comparisons between bupropion and dexamphetamine in a range of in vivo tests exploring dopaminergic transmission. Bredeloux P; Dubuc I; Costentin J Br J Pharmacol; 2007 Mar; 150(6):711-9. PubMed ID: 17293887 [TBL] [Abstract][Full Text] [Related]
4. Interaction of amineptine with agents modifying dopaminergic transmission. Chagraoui A; Vasse M; Protais P Clin Neuropharmacol; 1989; 12 Suppl 2():S19-31. PubMed ID: 2576526 [TBL] [Abstract][Full Text] [Related]
6. Relationship between the effects of dexamphetamine on locomotion and on striatal [3H]GBR 12783 binding in vivo. Vaugeois JM; Bonnet JJ; Costentin J Eur J Pharmacol; 1990 Mar; 178(2):221-7. PubMed ID: 2328762 [TBL] [Abstract][Full Text] [Related]
7. Effects of buspirone on dopamine dependent behaviours in rats. Dhavalshankh AG; Jadhav SA; Gaikwad RV; Gaonkar RK; Thorat VM; Balsara JJ Indian J Physiol Pharmacol; 2007; 51(4):375-86. PubMed ID: 18476392 [TBL] [Abstract][Full Text] [Related]
8. In vivo occupancy of the striatal dopamine uptake complex by various inhibitors does not predict their effects on locomotion. Vaugeois JM; Bonnet JJ; Duterte-Boucher D; Costentin J Eur J Pharmacol; 1993 Jan; 230(2):195-201. PubMed ID: 8422901 [TBL] [Abstract][Full Text] [Related]
9. Thermodynamics of the binding of BTCP (GK 13) and related derivatives on the dopamine neuronal carrier. Billaud G; Menard JF; Marcellin N; Kamenka JM; Costentin J; Bonnet JJ Eur J Pharmacol; 1994 Aug; 268(3):357-63. PubMed ID: 7805759 [TBL] [Abstract][Full Text] [Related]
10. Behavioral properties of GBR 12909, GBR 13069 and GBR 13098: specific inhibitors of dopamine uptake. Heikkila RE; Manzino L Eur J Pharmacol; 1984 Aug; 103(3-4):241-8. PubMed ID: 6237922 [TBL] [Abstract][Full Text] [Related]
11. Characteristics of the dopamine receptors involved in the anorectic effects of apomorphine in mice. Duterte-Boucher D; Naudin B; Costentin J Fundam Clin Pharmacol; 1989; 3(4):337-46. PubMed ID: 2553567 [TBL] [Abstract][Full Text] [Related]
12. Effects of dextromethorphan on dopamine dependent behaviours in rats. Gaikwad RV; Gaonkar RK; Jadhav SA; Thorat VM; Jadhav JH; Balsara JJ Indian J Exp Biol; 2007 Aug; 45(8):712-9. PubMed ID: 17877148 [TBL] [Abstract][Full Text] [Related]
13. Appearance of a stereotyped apomorphine-induced climbing in unresponsive DBA2 mice after subchronic manipulations of brain dopamine transmission. Duterte-Boucher D; Costentin J Psychopharmacology (Berl); 1989; 98(1):56-60. PubMed ID: 2543019 [TBL] [Abstract][Full Text] [Related]
14. The phencyclidine (PCP) analog N-[1-(2-benzo(B)thiophenyl) cyclohexyl]piperidine shares cocaine-like but not other characteristic behavioral effects with PCP, ketamine and MK-801. Koek W; Colpaert FC; Woods JH; Kamenka JM J Pharmacol Exp Ther; 1989 Sep; 250(3):1019-27. PubMed ID: 2674416 [TBL] [Abstract][Full Text] [Related]
15. Modulation by dopamine of [3H]N-[1-(2-benzo(b)thiophenyl)cyclohexyl]piperidine ([3H]BTCP, a phencyclidine derivative) binding to the dopamine uptake complex. Maurice T; Barbanel G; Kamenka JM; Vignon J Neuropharmacology; 1991 Jun; 30(6):591-8. PubMed ID: 1681444 [TBL] [Abstract][Full Text] [Related]
16. Effects of phencyclidine and methylphenidate on d-amphetamine-induced behaviors in reserpine pretreated rats. Fessler RG; Sturgeon RD; Meltzer HY Pharmacol Biochem Behav; 1980 Dec; 13(6):835-42. PubMed ID: 7193876 [TBL] [Abstract][Full Text] [Related]
17. Regional effects of amphetamine, cocaine, nomifensine and GBR 12909 on the dynamics of dopamine release and metabolism in the rat brain. Karoum F; Chrapusta SJ; Brinjak R; Hitri A; Wyatt RJ Br J Pharmacol; 1994 Dec; 113(4):1391-9. PubMed ID: 7889297 [TBL] [Abstract][Full Text] [Related]
18. Effects of benztropine on behavioral and toxic effects of cocaine: comparison with atropine and the selective dopamine uptake inhibitor 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenyl-propyl)-piperazine. Acri JB; Siedleck BK; Witkin JM J Pharmacol Exp Ther; 1996 Apr; 277(1):198-206. PubMed ID: 8613919 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological profile of the new potent neuroleptic ocaperidone (R 79,598). Megens AA; Awouters FH; Meert TF; Schellekens KH; Niemegeers CJ; Janssen PA J Pharmacol Exp Ther; 1992 Jan; 260(1):146-59. PubMed ID: 1370538 [TBL] [Abstract][Full Text] [Related]
20. Effects of the antidepressant trazodone, a 5-HT 2A/2C receptor antagonist, on dopamine-dependent behaviors in rats. Balsara JJ; Jadhav SA; Gaonkar RK; Gaikwad RV; Jadhav JH Psychopharmacology (Berl); 2005 May; 179(3):597-605. PubMed ID: 15614572 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]